We are seeking an ambitious post-doctoral scientist with strong research and communication skills to contribute to a high-visibility research program. Your work will contribute to the development of human-relevant New Approach Methodologies (NAMs) designed to detect and predict immune-mediated drug-induced liver injury (iDILI) -a leading cause of late-stage clinical failures and drug withdrawals that current preclinical tools are largely unable to anticipate. In this role, you will: Investigate how interactions between liver biology and the immune system contribute to drug-induced liver injury, working across hepatocyte biology, innate immune sensing, and adaptive immunity. Help build and apply human-relevant model systems that integrate liver and immune biology into a mechanistically informed, predictive safety platform. Contribute to a platform capable of identifying immune-mediated liver liabilities earlier in drug development, with the potential to change how the industry approaches this challenge. Work within a collaborative, academic-style postdoctoral group that leads NAMs innovation at Lilly, with close connections across drug metabolism, computational toxicology, translational medicine, and immunogenicity functions. Identify areas of key need across drug development and champion creative solutions to address those needs. Maintain external awareness and learning to benefit the organization. Present findings at conferences and publish in high quality peer-reviewed journals.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Entry Level
Education Level
Ph.D. or professional degree